Home › Funds › MONTANOVA CAPITAL, LLC › BHVN

MONTANOVA CAPITAL, LLC position in BHVN

BIOHAVEN LTD · Health Care

MONTANOVA CAPITAL, LLC reported holding 10,286,937 shares of BHVN (BIOHAVEN LTD) in its Q2 2026 13F filing — a position valued at US$153.1M, representing 2.80% of its reported portfolio and ranking #8 among its reported holdings. MONTANOVA CAPITAL, LLC has disclosed BHVN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)10.29M sh
Reported value held$153.07M
Portfolio Weight2.80%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How MONTANOVA CAPITAL, LLC's BHVN position evolved

MONTANOVA CAPITAL, LLC first disclosed a stake in BHVN in Q3 2023 at 4,005,600 shares (US$104.2M). The position peaked in Q3 2024 at 5,199,219 shares, worth US$259.8M. Across 12 filings, MONTANOVA CAPITAL, LLC increased the stake 4 time(s), trimmed it 1 time(s) and left it unchanged 6 time(s). The most recent filing (Q2 2026) shows 10,286,937 shares valued at US$153.1M. Notable position changes include a 30% increase in Q2 2024 (shares rose 44% over the following quarter), a 83% increase in Q4 2025 (shares fell 25% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 4.01M $104.19M New
Q4 2023 4.57M $195.72M Add
Q1 2024 4.00M $218.93M Reduce
Q2 2024 5.20M $180.46M Add
Q3 2024 5.20M $259.80M Hold
Q4 2024 5.62M $209.92M Add
Q1 2025 5.62M $135.11M Hold
Q2 2025 5.62M $79.30M Hold
Q3 2025 5.62M $84.36M Hold
Q4 2025 10.29M $116.14M Add
Q1 2026 10.29M $87.03M Hold
Q2 2026 10.29M $153.07M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BHVN and 13F data

BHVN (BIOHAVEN LTD) is a Health Care company. 29 other funds we track also report a position in BHVN — the largest reported positions include INFINITUM ASSET MANAGEMENT, LLC (US$93.0M), Royalty Pharma Sub-Manager, LLC (US$43.7M), Cormorant Asset Management, LP (US$38.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BHVN

All BHVN fund holders →

FAQ

How long has MONTANOVA CAPITAL, LLC held BHVN?

MONTANOVA CAPITAL, LLC has disclosed BHVN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is MONTANOVA CAPITAL, LLC's current position in BHVN?

As of Q2 2026, MONTANOVA CAPITAL, LLC holds 10.29M shares of BHVN (BIOHAVEN LTD), valued at $153.07M, representing 2.80% of its reported portfolio and ranking #8.

Has MONTANOVA CAPITAL, LLC been buying or selling BHVN?

In the latest 13F filing (Q2 2026), MONTANOVA CAPITAL, LLC held unchanged its position in BHVN. The position peaked in Q3 2024 at 5.20M shares.

Which other funds hold BHVN?

Other major institutional holders of BHVN include INFINITUM ASSET MANAGEMENT, LLC, Royalty Pharma Sub-Manager, LLC, Cormorant Asset Management, LP, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.